Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
Background This meta-analysis seeks to assess the efficacy and safety of pembrolizumab in individuals with advanced or recurrent cervical cancer.Methods Databases from PubMed, Embase, and the Cochrane Library were all thoroughly searched for pertinent research. Outcomes include complete response (CR...
Saved in:
Main Authors: | Xue Zhang, Wen-Jie Yin, Ai-Li Zhang, Xiao-Xiao Zhang, Li-Juan Ding, Jiao Zhang, Shu-Ting He, Jie-Ping Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Journal of Obstetrics and Gynaecology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/01443615.2024.2390564 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ConvXGB: A novel deep learning model to predict recurrence risk of early-stage cervical cancer following surgery using multiparametric MRI images
by: Ji Wu, et al.
Published: (2025-02-01) -
Efficacy and safety of immunotherapy for head and neck squamous cell carcinoma: a meta-analysis of randomized clinical trials
by: Cailing Jiang, et al.
Published: (2025-01-01) -
Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital
by: Gloria Juan-Carpena, et al.
Published: (2025-01-01) -
Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
by: Yin-Che Wang, et al.
Published: (2025-12-01) -
Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
by: Zhiyong Wan, et al.
Published: (2025-01-01)